Email This Article
Life & Money
Is It Safe? Pipeline Pain at AstraZeneca
By
David MacDougall
06/10/09 - 04:00 AM EDT
AstraZeneca is trying to boost its pipeline before it loses patents on key drugs. But it's unclear if its plan will work.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,441.12 | 1,116.07 | 2,237.27 | 36.40 |
Oil *
73.69
|
|
UP
112.23
|
UP
13.60
|
UP
25.58
|
UP
0.94
|
10 Yr
3.64%
SPDR Gold
107.65
|
|
+1.09%
|
+1.23%
|
+1.16%
|
+2.65%
|
Data delayed 20 minutes |
Connect with TheStreet